Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles2 certified filings for “Director - Decision Science, Immunology Product Lead” (Molecular and Cellular Biologists) in NJ: $96k–$138k, median $117k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles
- 2 certified filings for “Director - Decision Science, Immunology Product Lead” (Molecular and Cellular Biologists) in NJ: $96k–$138k, median $117k. Most were filed at wage level II (50%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Job Description Summary
WORK ARRANGEMENT: On-Site Working, #On-site
LOCATION: Cambridge, MA
RELOCATION SUPPORT: This role is based in Cambridge, United States. Novartis is unable to offer relocation support: please only apply if accessible.
We are seeking a highly motivated senior scientist with strong expertise in human immunology, immune profiling, and disease-relevant multicellular assay systems, combined with working knowledge of xRNA biotherapeutics and general immunogenicity principles. The successful candidate will lead immunology-focused studies to evaluate how novel biotherapeutic modalities, including antibody-oligonucleotide conjugates (AOCs) and related xRNA approaches, interact with immune cells and pathways. This role will generate mechanistic insights to inform therapeutic design, candidate selection, translational biomarker strategies, and early safety risk assessment, with a primary emphasis on immunological understanding and assay excellence.
Job Description
The Immunogenicity and Mechanistic Immunology unit in the Biologics Research Center (BRC) focuses son immune profiling and immunogenicity assessment that inform the characterization and optimization of biotherapeutics, including antibody-oligonucleotide conjugates (AOC) expansion across disease areas.
The scientist will join our Cambridge immunology team and work in matrix multidisciplinary project teams to design and execute immune profiling studies tailored to specific target tissues and disease to support the selection of safe and effective AOC in various disease areas.
KEY RESPONSIBILITIES:
• Design, establish, and execute immunology-focused profiling strategies to evaluate immune cell activation, modulation, cytokine release, innate immune sensing, adaptive immune responses, and disease-relevant functional outcomes.
• Competent and independent in executing and analyzing complex assays involving primary cells (including primary immune and non-immune cells), multicolor FACS analysis and functional immunological assays
• Generates hypotheses, designs and executes experiments, critically analyzes and interprets data, able to prioritize experiments and design follow-up experiments
• Generate mechanistic immunology data packages to support candidate optimization, translational biomarker hypotheses, safety risk assessment, and decision-making across discovery and early development programs.
• Collaborate closely with teams in immunology, disease biology, oligonucleotide biology, antibody engineering, bioanalytics, toxicology, and translational medicine to align assay strategy with program needs.
• Regularly communicate and present results, prepare reports, representing the Unit in project teams
• Open mindset, organization skills and ability and eagerness to develop novel assays or analysis tools based on project needs in different disease areas
• Maintain familiarity with scientific and technical literature pertinent to the projects
Video Link
• https://www.youtube.com/watch?v=aJbkTX4VueQ
ESSENTIAL REQUIREMENTS:
• Recent Ph.D. graduate (0-1 year) or MSc in Life Science, preferably immunology or cell biology plus 2–5-year research experience in human immunology or cell biology in industry or academic settings
• Deep expertise in human immunology and immune assay development, preferably using primary immune cells, multicellular assay systems, tissue-relevant models, or disease-relevant ex vivo platforms.
• Experience assessing immunogenicity, immune activation, cytokine release, anti-drug immune responses, or immune-related liabilities for biologics or emerging therapeutic modalities
• Demonstrated ability to critically analyze data, learn and combine new techniques and concepts quickly, design and
Apply on employer site ↗